← Insider buys
EBS

Emergent BioSolutions Inc. · Healthcare

Director Ronald Richard sold $263K of Emergent BioSolutions Inc.

Sold$263,077
$11.97Price
21,984Shares
−18%Stake

What EBS did after the filing

Filed Dec 9Copier in Dec 10
The stock from Wed, Dec 10 open, $11.46
+3.9%
S&P 500, same days
+2.3%

Measured over 30 trading days, to the Jan 26 close.

Traded Fri, Dec 5. Filed Tue, Dec 9, 6:01 PM ET, after the close. Returns use the Dec 10 open and the Jan 26 close. Not investment advice.